1Poddar N,Wang J C. Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab [ J]. Hematol Rep,2013,5 (1) :5 -7.
2George J N, AL Nouvi Z L. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic ure- mic syndromes [J3. Hematology Am Soc Hematol Educ Pro- gram, 2012:604 - 609.
4Guzman MR. B - cell depletion in autoimmune diseases. Ad- vances in autoimmunity [ J ]. Autoimmun Rev, 2009,8 ( 7 ) : 585 - 590.
5George JN, Woodson RD, Kiss JE, et al. Rituximab therapy for thrombotic thrombocytopenie purpura: a proposed study of the Transfusion Medieine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune - mediated disorders [J]. J Clin Apher,2006,21 (1) :49 -56.
